CLYM vs ERAS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 08, 2026

CLYM

48.2
AI Score
VS
CLYM Wins

ERAS

46.8
AI Score

Investment Advisor Scores

CLYM

48score
Recommendation
HOLD

ERAS

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CLYM ERAS Winner
Net Income -41.79M -227.52M CLYM
Operating Income -47.46M -235.53M CLYM
ROE -18.3% -62.9% CLYM
ROA -17.7% -52.3% CLYM
Total Assets 236.56M 435.05M ERAS
Cash 39.73M 42.54M ERAS
Current Ratio 26.58 8.29 CLYM
Free Cash Flow -38.01M -54.70M CLYM

Relative Price Performance (Last 90 Days)

CLYM 1M: -5.0% · 3M: -40.6% ERAS 1M: +5.3% · 3M: -14.3%

Current Technical Phase

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.6 · Price: $10.36

ERAS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.8 · Price: $15.66

Fundamentals Snapshot

Metric CLYM ERAS
Market Cap — —
Forward P/E -10.4 -24.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -0.81 -0.95
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.